• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapy induced iron deficiency in children treated with eltrombopag for immune thrombocytopenia.

作者信息

Lambert Michele P, Witmer Char M, Kwiatkowski Janet L

机构信息

Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Am J Hematol. 2017 Jun;92(6):E88-E91. doi: 10.1002/ajh.24705. Epub 2017 Mar 20.

DOI:10.1002/ajh.24705
PMID:28240793
Abstract
摘要

相似文献

1
Therapy induced iron deficiency in children treated with eltrombopag for immune thrombocytopenia.用艾曲泊帕治疗免疫性血小板减少症的儿童中治疗诱导的缺铁
Am J Hematol. 2017 Jun;92(6):E88-E91. doi: 10.1002/ajh.24705. Epub 2017 Mar 20.
2
[Development of thrombopoietin receptor agonists].[血小板生成素受体激动剂的研发]
Rinsho Ketsueki. 2009 Oct;50(10):1434-43.
3
Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice.血小板生成素受体激动剂治疗慢性难治性原发性免疫性血小板减少症：真实临床实践中的疗效和安全性数据
Ter Arkh. 2018 Aug 17;90(7):70-76. doi: 10.26442/terarkh201890770-76.
4
Thrombopoietin receptor agonists in immune thrombocytopenia of less than 6 months duration.病程小于6个月的免疫性血小板减少症中的血小板生成素受体激动剂
Intern Med J. 2014 May;44(5):519-21. doi: 10.1111/imj.12406.
5
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.促血小板生成素受体激动剂用于准备接受脾切除术的成人免疫性血小板减少症患者：一项回顾性观察性 GIMEMA 研究的结果。
Am J Hematol. 2016 May;91(5):E293-5. doi: 10.1002/ajh.24341. Epub 2016 Apr 4.
6
Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists.血小板生成素受体激动剂治疗的免疫性血小板减少症患者的静脉血栓栓塞和凝血活性
Br J Haematol. 2012 Sep;158(6):811-4. doi: 10.1111/j.1365-2141.2012.09227.x. Epub 2012 Jul 23.
7
Sustaining platelet counts in chronic ITP.维持慢性免疫性血小板减少症患者的血小板计数
Lancet. 2011 Jan 29;377(9763):358-60. doi: 10.1016/S0140-6736(10)61090-2. Epub 2010 Aug 23.
8
Infection-related transient loss of response and other early side effects in chronic ITP during treatment with thrombopoietin mimetics.血小板生成素模拟物治疗慢性免疫性血小板减少症期间与感染相关的短暂反应丧失及其他早期副作用。
Onkologie. 2011;34(1-2):10-3. doi: 10.1159/000323347. Epub 2011 Jan 17.
9
Immune thrombocytopenia successfully treated with eltrombopag following multiple therapies including romiplostim.在接受包括罗米司亭在内的多种治疗后，艾曲泊帕成功治疗免疫性血小板减少症。
Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s151-2. doi: 10.2450/2013.0135-13. Epub 2013 Oct 3.
10
Thrombopoietin-receptor agonists for children with immune thrombocytopenia: a systematic review.用于免疫性血小板减少症患儿的血小板生成素受体激动剂：一项系统评价
Expert Opin Pharmacother. 2017 Oct;18(15):1543-1551. doi: 10.1080/14656566.2017.1373091. Epub 2017 Sep 4.

引用本文的文献

1
Iron deficiency anemia following long-term eltrombopag treatment for aplastic anemia: a single-institution experience.长期使用艾曲泊帕治疗再生障碍性贫血后出现的缺铁性贫血：单机构经验
Int J Hematol. 2025 Feb 12. doi: 10.1007/s12185-025-03940-2.
2
Fluvastatin suppresses hemin-induced cell death, reactive oxygen species generation, and elevated labile iron pool.氟伐他汀可抑制血红素诱导的细胞死亡、活性氧生成及不稳定铁池升高。
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S284-S290. doi: 10.1016/j.htct.2024.09.2480. Epub 2024 Nov 7.
3
Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopag.
使用艾曲波帕治疗难治/复发性 Diamond-Blackfan 贫血。
Br J Haematol. 2024 May;204(5):2077-2085. doi: 10.1111/bjh.19357. Epub 2024 Mar 10.
4
Avatrombopag for adults with early versus chronic immune thrombocytopenia.阿伐曲泊帕治疗成人早期与慢性免疫性血小板减少症。
Am J Hematol. 2024 Feb;99(2):155-162. doi: 10.1002/ajh.27080. Epub 2023 Dec 8.
5
Long term use of eltrombopag in children with chronic immune thrombocytopenia: extended real life retrospective multicenter experience of the Italian Association of Pediatric Hematology and Oncology.艾曲泊帕在儿童慢性免疫性血小板减少症中的长期应用：意大利儿科血液学和肿瘤学协会的真实生活扩展回顾性多中心经验
Front Med (Lausanne). 2023 Jul 14;10:1214308. doi: 10.3389/fmed.2023.1214308. eCollection 2023.
6
Efficacy and Immunomodulating Properties of Eltrombopag in Aplastic Anemia following Autologous Stem Cell Transplant: Case Report and Review of the Literature.艾曲泊帕在自体干细胞移植后再生障碍性贫血中的疗效及免疫调节特性：病例报告与文献综述
Pharmaceuticals (Basel). 2022 Mar 30;15(4):419. doi: 10.3390/ph15040419.
7
Long-term eltrombopag for bone marrow failure depletes iron.长期使用艾曲波帕治疗骨髓衰竭会消耗铁。
Am J Hematol. 2022 Jun 1;97(6):791-801. doi: 10.1002/ajh.26543. Epub 2022 Mar 26.
8
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro.铁状态影响脐带血巨核细胞祖细胞对艾曲泊帕在体外的反应。
Blood Adv. 2022 Jan 11;6(1):13-27. doi: 10.1182/bloodadvances.2021004207.
9
Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol.三期随机临床试验：比较艾曲泊帕与标准一线药物治疗方案用于儿童新诊断免疫性血小板减少症（ITP）的疗效：研究方案。
BMJ Open. 2021 Aug 27;11(8):e044885. doi: 10.1136/bmjopen-2020-044885.
10
Successful Use of Eltrombopag in a Young Child With Chronic Immune Thrombocytopenia.艾曲泊帕在一名慢性免疫性血小板减少症幼儿中的成功应用。
Cureus. 2021 Jan 15;13(1):e12723. doi: 10.7759/cureus.12723.